Angela T.H. Kwan, MD(C), MSc

  • 2Articles
  • 2025Active
  • 14Collaborators
  • 3Citations

About

Angela T.H. Kwan, MD(C), MSc is affiliated with Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada. Angela T.H. Kwan has authored or co-authored 2 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2025. Their work focuses on COVID, Depression (MDD), and Suicide.

Publications

JCP
Global Population-Based Study on the Association Between Ketamine and Esketamine with Suicidality Using WHO VigiBase
Original Research

Global Population-Based Study on the Association Between Ketamine and Esketamine with Suicidality Using WHO VigiBase

July 7, 2025

The results do not provide causal evidence of worsening suicidality in persons receiving esketamine/ketamine; mixed results of increased and decreased risk of suicidality were reported with both agents.
, , , et al
JCP
Vortioxetine for Cognitive Impairment in MDD Post-COVID
Original Research

Vortioxetine for Cognitive Impairment in MDD Post-COVID

May 5, 2025

Measures of cognitive function and depressive symptoms improved to a greater extent with vortioxetine than with escitalopram or sertraline in post-COVID syndrome participants with MDD.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe